Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/HVE stock hub

FRA/HVE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/HVEis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.4B
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/HVEFRA/HVE
—
Loading chart…
In the news

Latest news · FRA/HVE

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E3.3
P25 n/aP50 n/aP75 n/a
ROE50.7
P25 n/aP50 n/aP75 n/a
ROIC13.9
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/HVE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
212
Groups with data
11
Currency
USD
Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
159
Employees Change
15%
Employees Change Percent
13.39
Enterprise value
EUR 1.2B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 1.4B
Price
EUR 19.4
Price currency
EUR
Rev Per Employee
2,294,744.89x
Sic
2836
Symbol
fra/HVE
Website
https://www.inva.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
30.47%
EV Earnings
2.74x
EV/EBIT
8.48x
EV/EBITDA
7.25x
EV/FCF
7.58x
EV/Sales
3.35x
FCF yield
11%
P/B ratio
1.23x
P/E ratio
3.28x
P/S ratio
3.93x
PE Ratio10 Y
11.61x
PE Ratio3 Y
14.03x
PE Ratio5 Y
10.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
39.51%
EBITDA Margin
45.81%
FCF margin
43.26%
Gross margin
74.1%
Gross Profit
EUR 270.4M
Gross Profit Growth
-5.51%
Gross Profit Growth Q
2.94%
Gross Profit Growth3 Y
6.77%
Gross Profit Growth5 Y
-1.88%
Net Income
EUR 437.4M
Net Income Growth3 Y
29.35%
Net Income Growth5 Y
14.79%
Pretax Margin
142.63%
Profit Margin
119.88%
Profit Per Employee
EUR 2.8M
ROA
6.72
Roa5y
12.02
ROCE
9.23
ROE
50.72
Roe5y
33.38
ROIC
13.94
Roic5y
21.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr10y
6.83%
Cagr15y
1.44%
Cagr1y
17.59%
Cagr3y
22.32%
Cagr5y
15.6%
EPS Growth3 Y
29.95
EPS Growth5 Y
20.21
FCF Growth
-8.76%
FCF Growth Q
-27.43%
FCF Growth3 Y
12.19%
FCF Growth5 Y
-10.83%
OCF Growth
-8.32%
OCF Growth Q
-27.43%
OCF Growth10 Y
25.46%
OCF Growth3 Y
12.39%
OCF Growth5 Y
-10.72%
Revenue Growth
13.75x
Revenue Growth Q
10.56x
Revenue Growth3 Y
9.82x
Revenue Growth5 Y
4.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.27
Assets
EUR 1.6B
Cash
EUR 530.7M
Current Assets
EUR 655.2M
Current Liabilities
EUR 31M
Debt
EUR 287.4M
Debt EBITDA
EUR 1.7
Debt Equity
EUR 0.25
Debt FCF
EUR 1.82
Equity
EUR 1.2B
Interest Coverage
9.54
Liabilities
EUR 429.3M
Long Term Assets
EUR 937.7M
Long Term Liabilities
EUR 398.3M
Net Cash
EUR 243.3M
Net Cash By Market Cap
EUR 16.95
Net Debt EBITDA
EUR -1.46
Net Debt Equity
EUR -0.21
Net Debt FCF
EUR -1.54
Tangible Book Value
EUR 995.8M
Tangible Book Value Per Share
EUR 13.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
21.13
Inventory Turnover
2.71
Net Working Capital
EUR 112.3M
Quick ratio
19.27
Working Capital
EUR 638.4M
Working Capital Turnover
EUR 0.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-44.22%
Dividend per share
EUR 0
Last Dividend
EUR 0.22

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
93.59%
1Y total return
17.58%
200-day SMA
17.59
3Y total return
83.02%
50-day SMA
19.56
50-day SMA vs 200-day SMA
50over200
5Y total return
106.38%
All Time High
33.33
All Time High Change
-41.79%
All Time High Date
2013-07-12
All Time Low
6.16
All Time Low Change
214.99%
All Time Low Date
2015-10-01
ATR
0.3
Ch YTD
16.87
High
19.4
High52
21
High52 Date
2026-02-26
High52ch
-7.62%
Low
19.3
Low52
14.2
Low52 Date
2025-10-15
Low52ch
36.62%
Ma50ch
-0.84%
Price vs 200-day SMA
10.29%
RSI
44
RSI Monthly
59.39
RSI Weekly
56.09
Sharpe ratio
0.53x
Sortino ratio
1.15
Total Return
-44.22%
Tr YTD
16.87
Tr15y
23.86%
Tr1m
-3%
Tr1w
-1.02%
Tr3m
5.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 144.2M
Operating Income Growth
-12.86
Operating Income Growth Q
-8.44
Operating Income Growth3 Y
-1.78
Operating Income Growth5 Y
-12.71
Operating margin
39.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
68,992,128%
Net Borrowing
-21,199.1
Shares Insiders
0.8%
Shares Institutions
101.41%
Shares Qo Q
-0.49%
Shares Yo Y
44.22%
Short Ratio
9.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
EUR 149.3M
Average Volume
62x
Bv Per Share
15.77
CAPEX
EUR -1.4M
Ch10y
93.59
Ch15y
15.2
Ch1m
-3
Ch1w
-1.02
Ch1y
17.58
Ch3m
5.44
Ch3y
83.02
Ch5y
106.4
Ch6m
7.18
Change
2.11%
Change From Open
0.52
Close
19
Days Gap
1.58
Depreciation Amortization
22,457,425.6
Earnings Date
2026-07-30
EBIT
EUR 144.2M
EBITDA
EUR 167.1M
EPS
EUR 4.94
F Score
4
FCF
EUR 157.8M
FCF EV Yield
13.18x
Financing CF
-10,215,059
Fiscal Year End
December
Founded
1,996
Goodwill
15,182,759.6
Graham Number
45.73809
Graham Upside
135.8
Income Tax
EUR 83M
Investing CF
97,291,979
Is Primary Listing
0
Last Earnings Date
2026-02-26
Last Report Date
2026-03-31
Lynch Fair Value
EUR 87.42
Lynch Upside
350.6
Ma150
17.91
Ma150ch
8.35%
Ma20
19.86
Ma20ch
-2.32%
Net CF
246,308,864
Next Earnings Date
2026-07-30
Open
19.3
P FCF Ratio
9.09
P OCF Ratio
9.01
Position In Range
100
Ppne
10,848,825.8
Price Date
2026-05-08
Price EBITDA
EUR 8.59
Ptbv Ratio
1.44
Relative Volume
1.13x
Revenue
364,864,437x
SBC By Revenue
2.35x
Share Based Comp
8,561,986
Tax By Revenue
22.74x
Tax Rate
15.94%
Tr6m
7.18%
Z Score
3
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/HVE pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/HVE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+17.6%
S&P 500 1Y: n/a
3Y total return
+83.0%
S&P 500 3Y: n/a
5Y total return
+106.4%
S&P 500 5Y: n/a
10Y total return
+93.6%
S&P 500 10Y: n/a
Ownership

Who owns FRA/HVE?

Insider, institutional, and short-interest positioning.

Institutional ownership
+101.4%
Share of float held by funds and institutions
Insider ownership
+0.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
9.2 days to cover
Y/Y dilution
+44.2%
Negative means the company is buying back shares.
Technical

FRA/HVE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
44.0
Neutral momentum band
Price vs 200-day MA
+10.3%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.53
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/HVE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/HVE stock rating?

fra/HVE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/HVE analysis?

The full report lives at /stocks/fra/HVE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/HVE?

The latest report frames fra/HVE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/HVE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.